LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab ozogamicin in AML. Mediterr J Hematol Infect Dis [Internet]. 2020 Apr. 27 [cited 2026 May 15];12(1):e2020020. Available from: https://www.mjhid.org/mjhid/article/view/2020.020